Clinical Trials Directory

Trials / Unknown

UnknownNCT01914042

Prediction of Inter-individual Differences in the Response to Morphine Versus Milnacipran in Patients With Sciatica

Prediction of Inter-individual Differences in the Response to Morphine by Psychophysical Assessment of Pain Enhancing and Inhibiting Mechanisms in Patients With Chronic Neuropathic Pain

Status
Unknown
Phase
Phase 2
Study type
Interventional
Enrollment
150 (estimated)
Sponsor
Rambam Health Care Campus · Academic / Other
Sex
All
Age
18 Years – 75 Years
Healthy volunteers
Not accepted

Summary

Clinical, psychophysical, behavioral or genetic factor will predict the response to opioid treatment in patients with chronic neuropathic pain.

Conditions

Interventions

TypeNameDescription
DRUGMorphine
DRUGMilnacipran

Timeline

Start date
2013-07-01
Primary completion
2019-07-01
Completion
2019-12-01
First posted
2013-08-01
Last updated
2019-04-02

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT01914042. Inclusion in this directory is not an endorsement.

Prediction of Inter-individual Differences in the Response to Morphine Versus Milnacipran in Patients With Sciatica (NCT01914042) · Clinical Trials Directory